Search Within

Michael Andrew Postow

Formats
  1. Journal Article (191)
  2. Meeting Abstract (137)
  3. Editorial (9)
  4. Review (9)
  5. Book Section (4)
  6. Guidelines (4)
  7. Research Letter (4)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Department of Medicine (362)
  2. Melanoma Disease Management Team (362)
  3. Melanoma and Immunotherapeutics Service (362)
  4. Solid Tumor Oncology Division (362)
  5. GSK Faculty (178)
  6. Hematologic Malignancies, Division of (103)

More Groups

People
  1. Jedd Wolchok (158)
  2. Margaret Callahan (95)
  3. Katherine Panageas (64)
  4. Alexander Shoushtari (63)
  5. Paul Chapman (54)
  6. Parisa Momtaz (36)

More People

Years
  1. 2025 (16)
  2. 2024 (19)
  3. 2023 (23)
  4. 2022 (23)
  5. 2021 (27)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Journal for ImmunoTherapy of Cancer (34)
  3. Clinical Cancer Research (16)
  4. Annals of Oncology (13)
  5. International Journal of Radiation Oncology, Biology, Physics (12)
  6. The Oncologist (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (92)
  2. Biomed Central Ltd (43)
  3. Oxford University Press (32)
  4. Elsevier Inc. (31)
  5. American Association for Cancer Research (24)
  6. Wiley Blackwell (21)

More Publishers

Results (362)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival, response duration, and activity by BRAF mutation (MT) status in a phase 1 trial of nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Kluger, H.; Sznol, M.; Callahan, M.; Postow, M.; Gordon, R.; Segal, N. H.; Rizvi, N.; Lesokhin, A.; Atkins, M. B.; Kirkwood, J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-programmed death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H.; Callahan, M. K.; Postow, M. A.; Gordon, R.; Seal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Genetic basis for clinical response to CTLA-4 blockade in melanoma
    Journal Article

    Snyder, A.; Makarov, V.; Merghoub, T.; Yuan, J.; Zaretsky, J. M.; Desrichard, A.; Walsh, L. A.; Postow, M. A.; Wong, P.; Ho, T. S. ; more...
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save
  • Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial
    Journal Article

    Robert, C.; Ribas, A.; Wolchok, J. D.; Hodi, F. S.; Hamid, O.; Kefford, R.; Weber, J. S.; Joshua, A. M.; Hwu, W. J.; Gangadhar, T. C.; more...
    Lancet (2014)

    Fulltext@MSK | Save
  • Pocket oncology
    Book Whole


    Wolters Kluwer Health | Lippincott Williams & Wilkins (2014)

    Fulltext@MSK | Save
  • Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes
    Journal Article

    Kitano, S.; Postow, M. A.; Ziegler, C. G. K.; Kuk, D.; Panageas, K. S.; Cortez, C.; Rasalan, T.; Adamow, M.; Yuan, J. D.; Wong, P.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Immune modulation in cancer with antibodies - Book review
    Journal Article

    Page, D. B.; Postow, M. A.; Callahan, M. K.; Allison, J. P.; Wolchok, J. D.
    Annual Review of Medicine (2014)

    Fulltext@MSK | Save
  • Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: A comprehensive retrospective review from a single institution
    Journal Article

    Ryder, M.; Callahan, M.; Postow, M. A.; Wolchok, J.; Fagin, J. A.
    Endocrine-Related Cancer (2014)

    Fulltext@MSK | Save
  • Checkpoint blocking antibodies in cancer immunotherapy
    Journal Article

    Kyi, C.; Postow, M. A.
    FEBS Letters (2014)

    Fulltext@MSK | Save
  • Combinations of radiation therapy and immunotherapy for melanoma: A review of clinical outcomes
    Journal Article

    Barker, C. A.; Postow, M. A.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save